Return To The Previous Page
Buy a Package
Number Of Visible Items Remaining : 3 Item

Effect of low-dose ATG on C-peptide production in new-onset type 1 diabetes

Effect of low-dose ATG on C-peptide production in new-onset type 1 diabetes
Predicted population mean of C-peptide AUC over time in placebo-treated and ATG-treated groups. Analysis at the 2-year endpoint p = 0.0005. Bars above and below the line indicate 95% CI.
ATG: anti-thymocyte globulin; AUC: area under the curve.
From: American Diabetes Association. Haller MJ, Long SA, Blanchfield JL, et al. Low-dose anti-thymocyte globulin preserves C-Peptide, reduces HbA1c, and increases regulatory to conventional T-cell ratios in new-onset type 1 diabetes: Two-year clinical trial data. Diabetes 2019; 68:1267. Copyright and all rights reserved. Material from this publication has been used with the permission of American Diabetes Association.
Graphic 141629 Version 1.0

Do you want to add Medilib to your home screen?